Literature DB >> 8875194

Age and racial distribution of prostatic intraepithelial neoplasia.

W A Sakr1, D J Grignon, G P Haas, L K Heilbrun, J E Pontes, J D Crissman.   

Abstract

AIMS: To study the prevalence, extent and evolution of high-grade prostatic intraepithelial neoplasia (HGPIN) in African-American and Caucasian men of a wide age range in order to help clarify the role this lesion may play in the racial differences of prostate cancer.
METHODS: The lesion was documented in step-sectioned, entirely submitted prostates of two study populations: 525 autopsied men who died of trauma and 1,000 patients who had retropubic radical prostatectomy for clinically localized carcinoma of the prostate.
RESULTS: We found that HGPIN starts in young individuals and increases progressively with advancing age in both races but is more prevalent in African-Americans. Additionally, the more extensive form of HGPIN with multifocal or diffuse involvement of the gland appears at a younger age in African-Americans.
CONCLUSIONS: Microscopic foci of HGPIN can be documented in males in the 3rd and 4th decades with the lesion becoming more extensive in older men. The finding that HGPIN is both more prevalent and its more diffuse form appears earlier in African-Americans, indicates a potentially important role for this lesion in the race-related discrepancies associated with this disease.

Entities:  

Mesh:

Year:  1996        PMID: 8875194     DOI: 10.1159/000474163

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  32 in total

Review 1.  Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.

Authors:  R Montironi; R Mazzucchelli; J R Marshall; P H Bartels
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

2.  Should Canadians be offered systematic prostate cancer screening? No.

Authors:  Michel Labrecque; France Légaré; Michel Cauchon
Journal:  Can Fam Physician       Date:  2007-06       Impact factor: 3.275

3.  Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.

Authors:  Isaac J Powell; Cathryn H Bock; Julie J Ruterbusch; Wael Sakr
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

Review 4.  Precursor lesions for prostate cancer.

Authors:  M R Feneley; C Busch
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

5.  More Is Not Always Better: Intuitions About Effective Public Policy Can Lead to Unintended Consequences.

Authors:  Ellen Peters; William Klein; Annette Kaufman; Louise Meilleur; Anna Dixon
Journal:  Soc Issues Policy Rev       Date:  2013-01-01

6.  Does screening for prostate cancer identify clinically important disease?

Authors:  M R Feneley
Journal:  Ann R Coll Surg Engl       Date:  1999-05       Impact factor: 1.891

Review 7.  Lung cancer screening.

Authors:  Antonio Gutierrez; Robert Suh; Fereidoun Abtin; Scott Genshaft; Kathleen Brown
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

8.  Applications of transrectal ultrasound in prostate cancer.

Authors:  C J Harvey; J Pilcher; J Richenberg; U Patel; F Frauscher
Journal:  Br J Radiol       Date:  2012-07-27       Impact factor: 3.039

9.  Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer.

Authors:  Lorna W Harries; John R B Perry; Paul McCullagh; Malcolm Crundwell
Journal:  BMC Cancer       Date:  2010-06-22       Impact factor: 4.430

10.  ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.

Authors:  Carlos L Morais; Liana B Guedes; Jessica Hicks; Alexander S Baras; Angelo M De Marzo; Tamara L Lotan
Journal:  Hum Pathol       Date:  2016-05-14       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.